Mechanisms of Persistent NF-κB Activity in the Bronchi of an Animal Model of Asthma
- 15 November 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (10) , 5822-5830
- https://doi.org/10.4049/jimmunol.165.10.5822
Abstract
In most cells trans-activating NF-κB induces many inflammatory proteins as well as its own inhibitor, IκB-α, thus assuring a transient response upon stimulation. However, NF-κB-dependent inflammatory gene expression is persistent in asthmatic bronchi, even after allergen eviction. In the present report we used bronchial brushing samples (BBSs) from heaves-affected horses (a spontaneous model of asthma) to elucidate the mechanisms by which NF-κB activity is maintained in asthmatic airways. NF-κB activity was high in granulocytic and nongranulocytic BBS cells. However, NF-κB activity highly correlated to granulocyte percentage and was only abrogated after granulocytic death in cultured BBSs. Before granulocytic death, NF-κB activity was suppressed by simultaneous addition of neutralizing anti-IL-1β and anti-TNF-α Abs to the medium of cultured BBSs. Surprisingly, IκB-β, whose expression is not regulated by NF-κB, unlike IκB-α, was the most prominent NF-κB inhibitor found in BBSs. The amounts of IκB-β were low in BBSs obtained from diseased horses, but drastically increased after addition of the neutralizing anti-IL-1β and anti-TNF-α Abs. These results indicate that sustained NF-κB activation in asthmatic bronchi is driven by granulocytes and is mediated by IL-1β and TNF-α. Moreover, an imbalance between high levels of IL-1β- and TNF-α-mediated IκB-β degradation and low levels of IκB-β synthesis is likely to be the mechanism preventing NF-κB deactivation in asthmatic airways before granulocytic death.Keywords
This publication has 47 references indexed in Scilit:
- Nuclear IκBβ Maintains Persistent NF-κB Activation in HIV-1-infected Myeloid CellsPublished by Elsevier ,1999
- Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Pro-inflammatory signaling: Last pieces in the NF-κB puzzle?Current Biology, 1998
- I kappa B epsilon, a novel member of the Ikappa B family, controls RelA and cRel NF-kappa B activityThe EMBO Journal, 1997
- Pathophysiology of asthmaBritish Journal of Clinical Pharmacology, 1996
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severityJournal of Allergy and Clinical Immunology, 1991
- The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB functionCell, 1990
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990